Redmond Paul C Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$29.38M

Insider Activity of Redmond Paul C

The largest sale of all time was on 2011-05-13 and amounted to 87200 shares of Edwards Lifesciences Corporation for $7.73M.

Biography of Redmond Paul C

No biography is available at this moment.

2013-05-13SaleEdwards Lifesciences Corporation
EW
CVP, Global Operations
10,000
0.0089%
$67.35$673,500+3.39%
2012-05-08SaleEdwards Lifesciences Corporation
EW
CVP, Global Operations
34,400
0.0298%
$84.95$2.92M+5.38%
2012-05-07SaleEdwards Lifesciences Corporation
EW
CVP, Global Operations
30,000
0.026%
$85.07$2.55M+5.26%
2012-02-15SaleEdwards Lifesciences Corporation
EW
CVP, Global Operations
4,800
0.0027%
$48.50$232,812+17.86%
2012-01-10SaleEdwards Lifesciences Corporation
EW
CVP, Global Operations
33,600
0.0293%
$73.91$2.48M+17.25%
2012-01-03SaleEdwards Lifesciences Corporation
EW
CVP, Global Operations
3,100
0.0028%
$73.00$226,300+20.6%
2011-05-13SaleEdwards Lifesciences Corporation
EW
CVP, Global Operations
87,200
0.0763%
$88.64$7.73M-16.87%
2011-05-09SaleEdwards Lifesciences Corporation
EW
CVP, CardioVations Surgcl Sys
2,334
0.002%
$88.20$205,859-16.69%
2011-02-14SaleEdwards Lifesciences Corporation
EW
CVP, CardioVations Surgcl Sys
2,800
0.0024%
$88.65$248,220-13.45%
2011-02-07SaleEdwards Lifesciences Corporation
EW
CVP, CardioVations Surgcl Sys
43,140
0.0378%
$87.21$3.76M-10.17%
2010-11-02SaleEdwards Lifesciences Corporation
EW
CVP, Global Corp. Operations
69,400
0.0611%
$64.21$4.46M+28.72%
2010-02-19SaleEdwards Lifesciences Corporation
EW
CVP, CardioVations Surgcl Sys
17,200
0.0246%
$73.27$1.26M+27.62%
2010-02-17SaleEdwards Lifesciences Corporation
EW
CVP, CardioVations Surgcl Sys
27,400
0.0383%
$70.99$1.95M+28.48%
2010-02-09SaleEdwards Lifesciences Corporation
EW
CVP, CardioVations Surgcl Sys
10,000
0.0139%
$68.40$684,000+32.88%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.